Azusa, CA, United States of America

Ismail H Al-Abdullah

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Beckman Research Institute, City of Hope. Active years: 2019-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ismail H Al-Abdullah. Retrieved from https://idiyas.com/inventor/ismail-h-al-abdullah

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 2.7

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Monrovia, CA (US) (2019)
  • Azusa, CA (US) (2023)

Company Filing History:


Years Active: 2019-2023

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Ismail H. Al-Abdullah: Innovator in Medical Research

Introduction

Ismail H. Al-Abdullah is a notable inventor based in Azusa, California, recognized for his contributions to medical research through his innovative patents. With a total of two patents to his name, his work significantly enhances our understanding of cellular behaviors and methodologies in the medical field.

Latest Patents

Al-Abdullah’s latest patents focus on two groundbreaking innovations:

1. **Stable Dithizone Solutions and Formulations**: This patent involves the development of an optimized Diphenylthiocarbazone or Dithizone (DTZ) solution. It is designed with preferred physical and chemical properties that aid in the characterization of human islets and insulin-producing cells differentiated from embryonic stem cells. The formulation, known as iDTZ (where "i" stands for islet), has been shown to be effective across various temperatures, time intervals, and cell types, proving robust in the identification of insulin-producing cells. Notably, iDTZ allows for high transition zinc binding, concentrating in these cells and facilitating the delineation of zinc levels in both tissue and liquid samples.

2. **Methods, Compositions, and Kits for Detection of Bacterial Proteases**: This patent presents novel fluorogenic and bioluminescent bacterial protease substrates that contain specific bacterial protease cleavage sites. These substrates are beneficial in the context of tissue dissociation, cell isolation, and cell detachment, particularly in preparing islet cells. The methods and kits outlined in this patent enable the assessment of bacterial protease activity, providing innovative tools for isolating primary and stem cells.

Career Highlights

Al-Abdullah works at City of Hope, a leading research and treatment center dedicated to cancer, diabetes, and other life-threatening diseases. His research endeavors aim to bridge the gap between basic science and clinical application, enhancing therapeutic techniques through innovative solutions in cellular biology.

Collaborations

Throughout his career, Ismail H. Al-Abdullah has collaborated with notable researchers, including Markus Kalkum and Meirigeng Qi. Their combined expertise fosters a rich environment for innovation and aids in advancing their shared goals in medical research.

Conclusion

Ismail H. Al-Abdullah exemplifies the impact of innovation in medical research. His patents on stable dithizone solutions and bacterial protease detection methods not only contribute to scientific knowledge but also provide practical applications that could significantly improve patient care. Through his ongoing work and collaborations, he continues to pave the way for future breakthroughs in the healthcare sector.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…